Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer

Patrizia Vici, Anna Crispo, Antonio Giordano, Luigi Di Lauro, Francesca Sperati, Irene Terrenato, Laura Pizzuti, Domenico Sergi, Marcella Mottolese, Claudio Botti, Maria Grimaldi, Immacolata Capasso, Giuseppe D'Aiuto, Maurizio Di Bonito, Flaviano Di Paola, Marcello Maugeri-Saccà, Maurizio Montella, Maddalena Barba

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Genomic and trascriptomic profiling has recently contributed details to the characterization of luminal B breast cancer. We explored the contribution of anthropometric, metabolic, and molecular determinants to the multifaceted heterogeneity of this breast cancer subtype, with a specific focus on the association between body mass index (BMI), pre-treatment fasting glucose, hormone receptors, and expression of human epidermal growth factor receptor 2 (HER2). Extensively annotated specimens were obtained from 154 women with luminal B breast cancer diagnosed at two Italian comprehensive cancer centres. Participants' characteristics were descriptively analyzed overall and by HER2 status (positive vs. negative). BMI (

Original languageEnglish
Pages (from-to)1708-1712
Number of pages5
JournalJournal of Cellular Physiology
Volume230
Issue number8
DOIs
Publication statusPublished - Aug 1 2015

Fingerprint

Breast Neoplasms
Body Mass Index
Hormones
Glucose
Fasting
human ERBB2 protein
Neoplasms
Therapeutics
glucose receptor

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology
  • Medicine(all)

Cite this

Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer. / Vici, Patrizia; Crispo, Anna; Giordano, Antonio; Lauro, Luigi Di; Sperati, Francesca; Terrenato, Irene; Pizzuti, Laura; Sergi, Domenico; Mottolese, Marcella; Botti, Claudio; Grimaldi, Maria; Capasso, Immacolata; D'Aiuto, Giuseppe; Bonito, Maurizio Di; Paola, Flaviano Di; Maugeri-Saccà, Marcello; Montella, Maurizio; Barba, Maddalena.

In: Journal of Cellular Physiology, Vol. 230, No. 8, 01.08.2015, p. 1708-1712.

Research output: Contribution to journalArticle

Vici, P, Crispo, A, Giordano, A, Lauro, LD, Sperati, F, Terrenato, I, Pizzuti, L, Sergi, D, Mottolese, M, Botti, C, Grimaldi, M, Capasso, I, D'Aiuto, G, Bonito, MD, Paola, FD, Maugeri-Saccà, M, Montella, M & Barba, M 2015, 'Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer', Journal of Cellular Physiology, vol. 230, no. 8, pp. 1708-1712. https://doi.org/10.1002/jcp.24891
Vici, Patrizia ; Crispo, Anna ; Giordano, Antonio ; Lauro, Luigi Di ; Sperati, Francesca ; Terrenato, Irene ; Pizzuti, Laura ; Sergi, Domenico ; Mottolese, Marcella ; Botti, Claudio ; Grimaldi, Maria ; Capasso, Immacolata ; D'Aiuto, Giuseppe ; Bonito, Maurizio Di ; Paola, Flaviano Di ; Maugeri-Saccà, Marcello ; Montella, Maurizio ; Barba, Maddalena. / Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer. In: Journal of Cellular Physiology. 2015 ; Vol. 230, No. 8. pp. 1708-1712.
@article{571c09eaadb141f392fbd4dbe12bd5ec,
title = "Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer",
abstract = "Genomic and trascriptomic profiling has recently contributed details to the characterization of luminal B breast cancer. We explored the contribution of anthropometric, metabolic, and molecular determinants to the multifaceted heterogeneity of this breast cancer subtype, with a specific focus on the association between body mass index (BMI), pre-treatment fasting glucose, hormone receptors, and expression of human epidermal growth factor receptor 2 (HER2). Extensively annotated specimens were obtained from 154 women with luminal B breast cancer diagnosed at two Italian comprehensive cancer centres. Participants' characteristics were descriptively analyzed overall and by HER2 status (positive vs. negative). BMI (",
author = "Patrizia Vici and Anna Crispo and Antonio Giordano and Lauro, {Luigi Di} and Francesca Sperati and Irene Terrenato and Laura Pizzuti and Domenico Sergi and Marcella Mottolese and Claudio Botti and Maria Grimaldi and Immacolata Capasso and Giuseppe D'Aiuto and Bonito, {Maurizio Di} and Paola, {Flaviano Di} and Marcello Maugeri-Sacc{\`a} and Maurizio Montella and Maddalena Barba",
year = "2015",
month = "8",
day = "1",
doi = "10.1002/jcp.24891",
language = "English",
volume = "230",
pages = "1708--1712",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer

AU - Vici, Patrizia

AU - Crispo, Anna

AU - Giordano, Antonio

AU - Lauro, Luigi Di

AU - Sperati, Francesca

AU - Terrenato, Irene

AU - Pizzuti, Laura

AU - Sergi, Domenico

AU - Mottolese, Marcella

AU - Botti, Claudio

AU - Grimaldi, Maria

AU - Capasso, Immacolata

AU - D'Aiuto, Giuseppe

AU - Bonito, Maurizio Di

AU - Paola, Flaviano Di

AU - Maugeri-Saccà, Marcello

AU - Montella, Maurizio

AU - Barba, Maddalena

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Genomic and trascriptomic profiling has recently contributed details to the characterization of luminal B breast cancer. We explored the contribution of anthropometric, metabolic, and molecular determinants to the multifaceted heterogeneity of this breast cancer subtype, with a specific focus on the association between body mass index (BMI), pre-treatment fasting glucose, hormone receptors, and expression of human epidermal growth factor receptor 2 (HER2). Extensively annotated specimens were obtained from 154 women with luminal B breast cancer diagnosed at two Italian comprehensive cancer centres. Participants' characteristics were descriptively analyzed overall and by HER2 status (positive vs. negative). BMI (

AB - Genomic and trascriptomic profiling has recently contributed details to the characterization of luminal B breast cancer. We explored the contribution of anthropometric, metabolic, and molecular determinants to the multifaceted heterogeneity of this breast cancer subtype, with a specific focus on the association between body mass index (BMI), pre-treatment fasting glucose, hormone receptors, and expression of human epidermal growth factor receptor 2 (HER2). Extensively annotated specimens were obtained from 154 women with luminal B breast cancer diagnosed at two Italian comprehensive cancer centres. Participants' characteristics were descriptively analyzed overall and by HER2 status (positive vs. negative). BMI (

UR - http://www.scopus.com/inward/record.url?scp=84928393812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928393812&partnerID=8YFLogxK

U2 - 10.1002/jcp.24891

DO - 10.1002/jcp.24891

M3 - Article

C2 - 25510909

AN - SCOPUS:84928393812

VL - 230

SP - 1708

EP - 1712

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 8

ER -